Peeling Skin Syndrome is a rare genetic disorder characterized by continuous shedding of the outermost layer of the skin. Due to its rarity, the prevalence of this syndrome is not well-documented. However, it is estimated to affect a very small number of individuals worldwide. The condition is typically inherited in an autosomal recessive manner, meaning both parents must carry the gene mutation for their child to be affected. Although more research is needed to determine the exact prevalence, it is considered to be an extremely uncommon disorder.
Peeling Skin Syndrome (PSS) is a rare genetic disorder characterized by the continuous shedding of the outermost layer of the skin. While the exact prevalence of PSS is not well-documented, it is considered an extremely rare condition.
Due to its rarity, there is limited data available on the number of individuals affected by PSS. However, it is estimated that the prevalence of PSS is less than 1 in 1,000,000 people worldwide. This indicates that PSS is a highly uncommon disorder.
Peeling Skin Syndrome can manifest in different forms, including non-inflammatory and inflammatory types. The non-inflammatory type typically begins in infancy or early childhood, while the inflammatory type may develop later in life. Both forms can cause significant discomfort and affect the quality of life for those affected.
Although PSS is a rare condition, it is crucial for individuals experiencing symptoms such as excessive skin peeling to consult with a dermatologist or medical professional for an accurate diagnosis and appropriate management.